REFERENCES
1. Sturm D, Orr BA, Toprak UH, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016;164:1060-1072.
2. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncol. 2021;23:1231-1251.
3. Holsten T, Lubieniecki F, Spohn M, et al. Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas. J Neuropathol Exp Neurol. 2021;80:52-59.
4. Łastowska M, Trubicka J, Sobocińska A, et al. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes. Acta Neuropathol Commun. 2020;8:105.
5. Korshunov A, Okonechnikov K, Schmitt-Hoffner F, et al. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation. Acta Neuropathol Commun. 2021;9:20.
6. Lambo S, Gröbner SN, Rausch T, et al. The molecular landscape of ETMR at diagnosis and relapse. Nature. 2019;576:274-280.
7. Raghuram N, Khan S, Mumal I, Bouffet E, Huang A. Embryonal tumors with multi-layered rosettes: a disease of dysregulated miRNAs. J Neurooncol. 2020;150:63-73.
8. Faoro D, von Bueren AO, Shalaby T, et al. Expression of O6-methylguanine-DNA methyltransferase in childhood medulloblastoma. J Neurooncol. 2011;103:59-69.
9. Oh J, Bilbao JM, Tsao MN, et al. Recurrent PNET with MGMT methylation responds to temozolomide. Can J Neurol Sci J Can Sci Neurol. 2009;36:654-657.
10. Torre M, Vasudevaraja V, Serrano J, et al. Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Acta Neuropathol Commun. 2020;8:107.
11. Dodgshun AJ, Fukuoka K, Edwards M, et al. Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns. Acta Neuropathol. 2020;140:765-776.